IRIS Accounts Production v25.4.0.155 12773942 director 1.2.24 31.1.25 31.1.25 false true false false false true false Ordinary 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 12773942 2024-01-31 12773942 2025-01-31 12773942 2024-02-01 2025-01-31 12773942 2023-01-31 12773942 2023-02-01 2024-01-31 12773942 2024-01-31 12773942 ns15:EnglandWales 2024-02-01 2025-01-31 12773942 ns14:PoundSterling 2024-02-01 2025-01-31 12773942 ns10:Director1 2024-02-01 2025-01-31 12773942 ns10:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 12773942 ns10:SmallEntities 2024-02-01 2025-01-31 12773942 ns10:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 12773942 ns10:SmallCompaniesRegimeForDirectorsReport 2024-02-01 2025-01-31 12773942 ns10:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 12773942 ns10:FullAccounts 2024-02-01 2025-01-31 12773942 1 2024-02-01 2025-01-31 12773942 ns10:OrdinaryShareClass1 2024-02-01 2025-01-31 12773942 ns5:CurrentFinancialInstruments 2025-01-31 12773942 ns5:CurrentFinancialInstruments 2024-01-31 12773942 ns5:Non-currentFinancialInstruments 2025-01-31 12773942 ns5:Non-currentFinancialInstruments 2024-01-31 12773942 ns5:ShareCapital 2025-01-31 12773942 ns5:ShareCapital 2024-01-31 12773942 ns5:RetainedEarningsAccumulatedLosses 2025-01-31 12773942 ns5:RetainedEarningsAccumulatedLosses 2024-01-31 12773942 ns10:RegisteredOffice 2024-02-01 2025-01-31 12773942 ns5:NetGoodwill 2024-02-01 2025-01-31 12773942 ns5:IntangibleAssetsOtherThanGoodwill 2024-02-01 2025-01-31 12773942 ns5:NetGoodwill 2024-01-31 12773942 ns5:IntangibleAssetsOtherThanGoodwill 2024-01-31 12773942 ns5:NetGoodwill 2025-01-31 12773942 ns5:IntangibleAssetsOtherThanGoodwill 2025-01-31 12773942 ns5:NetGoodwill 2024-01-31 12773942 ns5:IntangibleAssetsOtherThanGoodwill 2024-01-31 12773942 ns5:PlantMachinery 2024-01-31 12773942 ns5:PlantMachinery 2024-02-01 2025-01-31 12773942 ns5:PlantMachinery 2025-01-31 12773942 ns5:PlantMachinery 2024-01-31 12773942 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-01-31 12773942 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-01-31 12773942 ns5:Secured 2025-01-31 12773942 ns5:Secured 2024-01-31 12773942 ns10:OrdinaryShareClass1 2025-01-31

REGISTERED NUMBER: 12773942 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 January 2025

for

Lillibet Healthcare2 Limited

Lillibet Healthcare2 Limited (Registered number: 12773942)

Contents of the Financial Statements

for the Year Ended 31 January 2025

Page |

Balance Sheet | 1 |

Notes to the Financial Statements | 3 |

Lillibet Healthcare2 Limited (Registered number: 12773942)

Balance Sheet

31 January 2025

| 31.1.25 | 31.1.24 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Intangible assets | 4 | 504,558 |  | 463,772 |  |

Tangible assets | 5 | 27,963 |  | 27,729 |  |

532,521 |  | 491,501 |  |

CURRENT ASSETS

Debtors | 6 | 215,523 |  | 117,992 |  |

Cash at bank and in hand | 3,538 |  | 21,797 |  |

219,061 |  | 139,789 |  |

CREDITORS

Amounts falling due within one year | 7 | 366,220 |  | 287,269 |  |

NET CURRENT LIABILITIES | (147,159 | ) | (147,480 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | 385,362 |  | 344,021 |  |

CREDITORS

Amounts falling due after more than one year | 8 | (222,351 | ) | (234,480 | ) |

PROVISIONS FOR LIABILITIES | (6,932 | ) | (6,932 | ) |

NET ASSETS | 156,079 |  | 102,609 |  |

CAPITAL AND RESERVES

Called up share capital | 10 | 100 |  | 100 |  |

Retained earnings | 155,979 |  | 102,509 |  |

SHAREHOLDERS' FUNDS | 156,079 |  | 102,609 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Lillibet Healthcare2 Limited (Registered number: 12773942)

Balance Sheet - continued

31 January 2025

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 January 2026 and were signed by:

Dr S Krishnankutty - Director

Lillibet Healthcare2 Limited (Registered number: 12773942)

Notes to the Financial Statements

for the Year Ended 31 January 2025

1. | STATUTORY INFORMATION

| Lillibet Healthcare2 Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

| Registered number: | 12773942

| Registered office: | 4 Gardener Place

| Biddenham

| Bedford

| Bedfordshire

| MK40 4QU

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Significant judgements and estimates

| In the application of the company's accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

| The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Goodwill

| Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 20 years.

| For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

| Intangible assets

| Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

| Development costs are being amortised evenly over their estimated useful life of six years.

Lillibet Healthcare2 Limited (Registered number: 12773942)

Notes to the Financial Statements - continued

for the Year Ended 31 January 2025

2. | ACCOUNTING POLICIES - continued

| Tangible fixed assets

| Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

| Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

| Plant and machinery |  | 25% reducing balance method |  |

| The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

| Impairment of fixed assets

| At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

| Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

| If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

| Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

| Cash and cash equivalents

| Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Lillibet Healthcare2 Limited (Registered number: 12773942)

Notes to the Financial Statements - continued

for the Year Ended 31 January 2025

2. | ACCOUNTING POLICIES - continued

| Financial instruments

| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

| Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

| Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

| Basic financial assets

| Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

| Classification of financial liabilities

| Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

| Basic financial liabilities

| Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

| Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

| Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

| Equity instruments

| Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Lillibet Healthcare2 Limited (Registered number: 12773942)

Notes to the Financial Statements - continued

for the Year Ended 31 January 2025

2. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 24 (2024 - 24 ) .

4. | INTANGIBLE FIXED ASSETS

| Other |

| intangible |

| Goodwill |  | assets |  | Totals

£ | £ | £ |

| COST

| At 1 February 2024 | 542,120 |  | - |  | 542,120 |  |

| Additions | - |  | 81,470 |  | 81,470 |  |

| At 31 January 2025 | 542,120 |  | 81,470 |  | 623,590 |  |

| AMORTISATION

| At 1 February 2024 | 78,348 |  | - |  | 78,348 |  |

| Charge for year | 27,106 |  | 13,578 |  | 40,684 |  |

| At 31 January 2025 | 105,454 |  | 13,578 |  | 119,032 |  |

| NET BOOK VALUE

| At 31 January 2025 | 436,666 |  | 67,892 |  | 504,558 |  |

| At 31 January 2024 | 463,772 |  | - |  | 463,772 |  |

Lillibet Healthcare2 Limited (Registered number: 12773942)

Notes to the Financial Statements - continued

for the Year Ended 31 January 2025

5. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

£ |

| COST

| At 1 February 2024 | 52,736 |  |

| Additions | 7,166 |  |

| At 31 January 2025 | 59,902 |  |

| DEPRECIATION

| At 1 February 2024 | 25,007 |  |

| Charge for year | 6,932 |  |

| At 31 January 2025 | 31,939 |  |

| NET BOOK VALUE

| At 31 January 2025 | 27,963 |  |

| At 31 January 2024 | 27,729 |  |

6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.1.25 |  | 31.1.24

£ | £ |

| Trade debtors | 110,506 |  | 70,137 |  |

| Other debtors | 105,017 |  | 47,855 |  |

215,523 |  | 117,992 |  |

7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

| 31.1.25 |  | 31.1.24

£ | £ |

| Bank loans and overdrafts | 20,000 |  | 20,998 |  |

| Trade creditors | 14,503 |  | 34,237 |  |

| Taxation and social security | 16,551 |  | 38,431 |  |

| Other creditors | 315,166 |  | 193,603 |  |

366,220 |  | 287,269 |  |

8. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

| 31.1.25 |  | 31.1.24

£ | £ |

| Bank loans | 222,351 |  | 234,480 |  |

9. | SECURED DEBTS

| The following secured debts are included within creditors:

| 31.1.25 |  | 31.1.24

£ | £ |

| Bank loans | 242,351 |  | 255,478 |  |

| The bank loan is secured by a fixed and floating charge over the assets of the company.

Lillibet Healthcare2 Limited (Registered number: 12773942)

Notes to the Financial Statements - continued

for the Year Ended 31 January 2025

10. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 31.1.25 |  | 31.1.24

| value: | £ | £ |

| 100 | Ordinary | £1 | 100 |  | 100 |  |

11. | RELATED PARTY DISCLOSURES

| During the year, the company was charged rent of £81,948 (2024: £81,948) by a company in which the director has an interest.

| Included within other debtors is an amount of £Nil (2024: £47,855) owed by company in which the director has an interest.

| Included within other creditors is an amount of £236,611 (2024: £119,262) owed to a company in which the director has an interest.

12. | ULTIMATE CONTROLLING PARTY

| The company is controlled by the director.